Open AccessAntisense TR3 Orphan Receptor Can Increase Prostate Cancer Cell Viability with Etoposide Treatment
Author(s) -
H. Uemura
Publication year - 1998
Publication title -
endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.674
H-Index - 257
eISSN - 1945-7170
pISSN - 0013-7227
DOI - 10.1210/en.139.5.2329
Subject(s) - lncap , prostate cancer , orphan receptor , cancer research , androgen receptor , neuron derived orphan receptor 1 , etoposide , biology , transfection , ror1 , prostate , endocrinology , receptor , cancer , medicine , nuclear receptor , cell culture , genetics , transcription factor , gene , platelet derived growth factor receptor , chemotherapy , growth factor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom